Cargando…

Predictive value of soluble ST-2 for changes of cardiac function and structure in breast cancer patients receiving chemotherapy

The current study was to evaluate soluble ST-2 level and left ventricular ejection fraction (LVEF) in patients with breast cancer receiving doxorubicin or trastuzumab treatment for 6 months and determine whether soluble ST-2 level can be used to predictive left ventricular function impairment. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Guoding, Zhai, Jianfeng, Huang, Xinting, Zheng, Dongdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160077/ https://www.ncbi.nlm.nih.gov/pubmed/30235730 http://dx.doi.org/10.1097/MD.0000000000012447

Ejemplares similares

Prevalence and Factors Associated with BRCA1/2 Gene Mutation in Chinese Populations with Breast Cancer
por: Huang, Guoding, et al.
Publicado: (2022)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
por: Cao, Maria D, et al.
Publicado: (2012)

The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
por: Geenen, Laurie W., et al.
Publicado: (2019)

Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Zheng, Yi-Zi, et al.
Publicado: (2022)

Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
por: Zhang, Rongcheng, et al.
Publicado: (2014)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020)

Prognostic value of soluble ST2 in adults with congenital heart disease
por: Geenen, Laurie W, et al.
Publicado: (2019)

Predictive value of phosphorylated mammalian target of rapamycin for disease-free survival in breast cancer patients receiving neoadjuvant chemotherapy
por: WANG, SHUO, et al.
Publicado: (2014)

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients
por: Choi, Yu Bum, et al.
Publicado: (2020)

Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates
por: Keddis, Mira T., et al.
Publicado: (2017)

The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
por: Yang, Chaojun, et al.
Publicado: (2021)

Weight Changes in Women Receiving Chemotherapy for Non-Metastatic Breast Cancer in Saudi Arabia
por: Al-Hajeili, Marwan, et al.
Publicado: (2021)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Bae, Soong June, et al.
Publicado: (2022)

Serum soluble ST2 is associated with ER-positive breast cancer
por: Lu, Da-peng, et al.
Publicado: (2014)

Exercise-induced Changes in Soluble ST2 Concentrations in Marathon Runners
por: AENGEVAEREN, VINCENT L., et al.
Publicado: (2019)

Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention
por: Chang, Shu-min, et al.
Publicado: (2022)

Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease
por: Laqqan, Mohammed, et al.
Publicado: (2018)

Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients
por: Hayek, Ahmad, et al.
Publicado: (2021)

Long-term tolerance and cardiac function in breast cancer patients receiving trastuzumab therapy
por: Huang, Ping, et al.
Publicado: (2016)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015)

Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
por: Cui, Yameng, et al.
Publicado: (2018)

Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1
por: Matilla, Lara, et al.
Publicado: (2020)

Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction
por: Huang, Wei-Ping, et al.
Publicado: (2018)

Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
por: do Nascimento, Talita Garcia, et al.
Publicado: (2014)

Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving Chemotherapy
por: Zou, Linglong, et al.
Publicado: (2016)

Cardiac function in women receiving dual anti-Her2 antibodies (trastuzumab and pertuzumab) combined with chemotherapy for breast cancer
por: Zekri, Jamal, et al.
Publicado: (2023)

Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study
por: Sabbatinelli, Jacopo, et al.
Publicado: (2022)

Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy
por: Hung, Olivia Y, et al.
Publicado: (2015)

Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy
por: Chang, Hsien-Yuan, et al.
Publicado: (2021)

The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
por: Gao, Siming, et al.
Publicado: (2023)

Positive association between heart dosimetry parameters and a novel cardiac biomarker, solubleST‐2, in thoracic cancer chest radiation
por: Zeng, Zhi‐min, et al.
Publicado: (2020)

An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy
por: Dieli‐Conwright, Christina M., et al.
Publicado: (2016)

Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome
por: Celic, Vera, et al.
Publicado: (2016)

Prognostic value of sCD14-ST (presepsin) in cardiac surgery
por: Popov, Dmitry, et al.
Publicado: (2015)

Application of an automatic segmentation method for evaluating cardiac structure doses received by breast radiotherapy patients
por: Jung, Jae Won, et al.
Publicado: (2021)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p9gt89p7qgkj7c2bua7c5mqe10